← FDA Drug Approvals (Drugs@FDA)

HEPARIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EMERGE BIOSCIENCE · Approved 2020-02-24

Drug application

FDA Application #

ANDA211004

Application type

Abbreviated New Drug Application (Generic)

Brand name

HEPARIN SODIUM

Generic name

HEPARIN SODIUM

Active ingredients

HEPARIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

EMERGE BIOSCIENCE

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2020-02-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown